Wright Medical Group completed its acquisition of BioMimetic Therapeutics, a deal which began back in November, for about $190 million, according to Zacks. Wright will pay another $190 million if BioMimetic's Augment Bone Graft technology receives FDA approval, and a decision is expected to be made between April 2013 and January 2014.
Wright Medical Group develops and manufactures orthopedic devices and will incorporate BioMimetic's biologics offerings.
More Articles on Devices:
Invibio to Attend 2013 AAOS Annual Meeting
OsteoMed Launches QWIK Bone Fill Material
TranS1 Posts $12M 4Q Loss
Wright Medical Group develops and manufactures orthopedic devices and will incorporate BioMimetic's biologics offerings.
More Articles on Devices:
Invibio to Attend 2013 AAOS Annual Meeting
OsteoMed Launches QWIK Bone Fill Material
TranS1 Posts $12M 4Q Loss